MegaZone and Hanmi Science to Cooperate on AX-Driven Innovation in Pharma and Health Care
TECHWORLD ·
✦ AI Summary
MegaZone and Hanmi Science signed a memorandum of understanding to identify AI transformation (AX) initiatives tailored to the pharmaceutical and health care industries.
The agreement includes combining MegaZone’s AI and cloud technologies with Hanmi Science’s experience in the pharmaceutical and health care industries to strengthen AX-based workplace innovation and digital transformation capabilities.
The two companies plan to form a working-level consultative body to review application areas and implementation plans, and to expand the scope of cooperation across Hanmi Group affiliates based on performance and potential for use.
MegaZone said it will work with Hanmi Science to identify AI transformation (AX) initiatives tailored to the pharmaceutical and health care industries. MegaZone also said it will jointly push digital workplace innovation across the Hanmi Group as a whole.
To that end, the two companies signed a memorandum of understanding for AX-based workplace innovation. The agreement calls for combining MegaZone’s AI and cloud technologies with Hanmi Science’s experience in the pharmaceutical and health care industries.
Under the agreement, the two companies plan to identify AX-based workplace innovation projects and strengthen their digital transformation capabilities. They also agreed to jointly pursue AI and digital innovation businesses.
The two companies decided to focus on discovering AI services that reflect the work characteristics of the pharmaceutical and health care industries. Rather than simply introducing general-purpose AI, they plan to jointly design services that solve real on-site work problems and can be put to practical use.
After the agreement, they will form a working-level consultative body. The body will review specific application areas and implementation plans, and will identify initial workplace innovation projects.
They plan to gradually expand the scope of cooperation based on performance and potential for use. The expansion target covers Hanmi Group affiliates as a whole.
Hanmi Science is currently running the 'Hanmi AI Boost Program' for group affiliates. Example participants include Hanmi Pharm. The program aims to expand employees' use of AI, identify real workplace innovation cases, and build an AX-based foundation at the group level. Kim Jae-kyo, CEO of Hanmi Science, said AI is not merely a tool for improving work efficiency but a core technology that determines corporate competitiveness, and added that the agreement will help expand AX-based workplace innovation across the Hanmi Group and build a digital work environment that allows employees to work more efficiently.
MegaZone has experience in workplace innovation in the AI and cloud fields. It will support the Hanmi Group in identifying AX initiatives and implementing services. It also plans to link accumulated data and work experience in the pharmaceutical and health care industries with AI, while focusing on improving real-world applicability.
Jang Ji-hwang, CEO of MegaZone, said that creating tangible business results with AI requires combining technology with a deep understanding of the relevant industry and work. He added that, based on that premise, the company will pursue a business model capable of creating new value by combining Hanmi Science’s pharmaceutical and health care expertise with MegaZone’s cloud- and AI-based workplace innovation experience.
Source: TECHWORLD · Kim Seung-gi
Original: https://www.epnc.co.kr/news/articleView.html?idxno=406273
References
This article was produced with the help of an automated content generation algorithm.
Source: TECHWORLD
View originalThis article was summarized and organized by BizCrush based on the original article from TECHWORLD. For exact quotations and full details, please refer to the original article.